VMware, Inc. (NYSE:VMW) preannounced better than expected results for Q2 and a new CEO causing Wells Fargo to think the company’s changes in management set the stage for a reunification with EMC (NYSE:EMC). The firm believes that this move will push VMware’s stock to advance, and the firm keeps its Outperform rating on the stock.
Don’t Miss: Is Apple Duping Its Portuguese Buyers?
Sally Beauty Holdings Inc. (NYSE:SBH) should be bought on weakness after its preannouncement that it had better than expected Q3 results and secondary offering, according to Baird. The firm thinks it is a solid defensive holding since it has strong cash flow, debt reductions, and investor brand awareness. Shares have an Outperform rating and a $31 price target.
Intel Corporation (NASDAQ:INTC) is still attractive after Q2 results, states Baird. Although the company had a lowered full year outlook, Baird believes it delivered solid execution in a difficult environment. Baird thinks the new products from the company and manufacturing advantages will transform into market share gains. The shares have an Outperform rating and a $33 price target.
VIVUS Inc. (NASDAQ:VVUS) has obtained FDA approval for its anti-obesity drug causing Wells Fargo to believe that the company may face reimbursement challenges, a restrictive distribution network, and challenges with actual patient compliance. The firm does not recommend buying VIVUS stock today, and keeps a Market Perform rating on the stock.
EMC Corporation (NYSE:EMC) estimates were adjusted by Credit Suisse in order to reflect macro pressures, but the firm noted the company has a significant 2H 2012 product cycle. the firm keeps its Outperform rating.
Don’t Miss: Vivus BREAKTHROUGH Opens Up the Obesity Market.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.